345 related articles for article (PubMed ID: 31935290)
61. Philadelphia chromosome positive acute lymphoblastic leukemia in adults: Therapeutic options and dilemmas in 2020.
Muffly L; Kebriaei P
Semin Hematol; 2020 Jul; 57(3):137-141. PubMed ID: 33256903
[TBL] [Abstract][Full Text] [Related]
62. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Czyz A; Ottmann O; Baron F; Brissot E; Ciceri F; Cornelissen JJ; Esteve J; Gorin NC; Savani B; Schmid C; Mohty M; Nagler A
Cancer; 2016 Oct; 122(19):2941-51. PubMed ID: 27309127
[TBL] [Abstract][Full Text] [Related]
63. The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis.
Igwe IJ; Yang D; Merchant A; Merin N; Yaghmour G; Kelly K; Ramsingh G
Br J Haematol; 2017 Nov; 179(4):618-626. PubMed ID: 29047122
[TBL] [Abstract][Full Text] [Related]
64. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
Uckun FM; Nachman JB; Sather HN; Sensel MG; Kraft P; Steinherz PG; Lange B; Hutchinson R; Reaman GH; Gaynon PS; Heerema NA
Leuk Lymphoma; 1999 Mar; 33(1-2):101-6. PubMed ID: 10194126
[TBL] [Abstract][Full Text] [Related]
65. Adults with Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission.
Aldoss I; Kamal MO; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2019 Feb; 25(2):e41-e45. PubMed ID: 30292743
[TBL] [Abstract][Full Text] [Related]
66. Philadelphia chromosome-positive acute lymphoblastic leukemia: a cytogenetic study of 33 patients diagnosed between 1981 and 2008.
De Braekeleer E; Douet-Guilbert N; Morel F; Le Bris MJ; Basinko A; Berthou C; Morice P; Férec C; De Braekeleer M
Anticancer Res; 2010 Feb; 30(2):569-73. PubMed ID: 20332472
[TBL] [Abstract][Full Text] [Related]
67. Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paper.
Soverini S; Albano F; Bassan R; Fabbiano F; Ferrara F; Foà R; Olivieri A; Rambaldi A; Rossi G; Sica S; Specchia G; Venditti A; Barosi G; Pane F
Cancer Med; 2020 May; 9(9):2960-2970. PubMed ID: 32154668
[TBL] [Abstract][Full Text] [Related]
68. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aldoss I; Stiller T; Cao TM; Palmer JM; Thomas SH; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1326-9. PubMed ID: 25842050
[TBL] [Abstract][Full Text] [Related]
69. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
[TBL] [Abstract][Full Text] [Related]
70. Advances in the Genetics and Therapy of Acute Lymphoblastic Leukemia.
Chiaretti S; Gianfelici V; O'Brien SM; Mullighan CG
Am Soc Clin Oncol Educ Book; 2016; 35():e314-22. PubMed ID: 27249738
[TBL] [Abstract][Full Text] [Related]
71. How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia.
Frisch A; Ofran Y
Haematologica; 2019 Nov; 104(11):2135-2143. PubMed ID: 31582548
[TBL] [Abstract][Full Text] [Related]
72. Optimal approach to treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: how to best use all the available tools.
Ribera JM
Leuk Lymphoma; 2013 Jan; 54(1):21-7. PubMed ID: 22762547
[TBL] [Abstract][Full Text] [Related]
73. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience.
Tekgündüz E; Göker H; Kaynar L; Sarı İ; Pala Ç; Doğu MH; Öztürk E; Turgut B; Korkmaz S; Tetik A; Büyükaşık Y; Hacıoğlu SK; Bozdağ SC; Özdemir E; Altuntaş F
Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):269-74. PubMed ID: 26927932
[TBL] [Abstract][Full Text] [Related]
74. SOHO State of the Art Update and Next Questions: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Short NJ; Kantarjian H; Pui CH; Goldstone A; Jabbour E
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):439-446. PubMed ID: 29853276
[TBL] [Abstract][Full Text] [Related]
75. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.
Fielding AK
Blood; 2010 Nov; 116(18):3409-17. PubMed ID: 20656928
[TBL] [Abstract][Full Text] [Related]
76. [Clinical analysis of adult Philadelphia chromosome-positive acute lymphoblastic leukemia with p16 gene deletion].
He BL; Xu N; Li YL; Pan CY; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Zhou HS; Liu QF; Liu XL
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):204-209. PubMed ID: 28395443
[No Abstract] [Full Text] [Related]
77. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
[TBL] [Abstract][Full Text] [Related]
78. Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.
Yoshimura T; Nakane T; Hirose A; Koh H; Nakamae M; Aimoto M; Nishimoto M; Hayashi Y; Terada Y; Nakamae H; Hino M
Osaka City Med J; 2013 Jun; 59(1):9-21. PubMed ID: 23909077
[TBL] [Abstract][Full Text] [Related]
79. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E
Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851
[TBL] [Abstract][Full Text] [Related]
80. Genetics and prognosis of ALL in children vs adults.
Roberts KG
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):137-145. PubMed ID: 30504302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]